New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook

E-ISSN： 1875-5704|12|6|652-667

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.12, Iss.6, 2015-12, pp. : 652-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of orally disintegrating tablets comprising controlled-release multiparticulate beads

By Venkatesh Gopi M. Stevens Phillip J. Lai Jin-Wang

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 12, 2012-12 ,pp. : 1428-1440

Informa Healthcare

Access to resources Recommend Favorite

Fast and pH-dependent release of domperidone from orally disintegrating tablets

By Assaf Shereen M.

Pharmaceutical Development and Technology, Vol. 18, Iss. 4, 2013-08 ,pp. : 897-905

Informa Healthcare

Access to resources Recommend Favorite

Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet

By Wei Qionghua Yang Feifei Luan Libiao

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 6, 2013-06 ,pp. : 928-934

Informa Healthcare

Access to resources Recommend Favorite

A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustained-release diclofenac potassium orally disintegrating tablet incorporating eudragit ERL/ERS: possibility of specific diclofenac-polymer interaction

By Qandil Amjad

Journal of Pharmaceutical Investigation, Vol. 43, Iss. 3, 2013-06 ,pp. : 171-183

Springer Publishing Company

Access to resources Recommend Favorite